Observational Study, Use of Canakinumab Administered Subcutaneously in the Treatment COVID-19 Pneumonia
Clinical trial NCT04348448 · TERMINATED
Trial details
- NCT number
- NCT04348448
- Sponsor
- AUSL Romagna Rimini
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-01
- Primary completion
- 2020-05-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.